Stemexpress, LLC
Folsom, CA Doing business as CGT Global
- UEI
- V6D4CLG1QU37
- CAGE
- 5VLJ3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325414 Biological Product (except Diagnostic) Manufacturing
- 541611 Administrative Management and General Management Consulting Services
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541720 Research and Development in the Social Sciences and Humanities
- 561320 Temporary Help Services
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- 1743 Creekside Dr #200, Folsom, CA 95630, USA
- Website
- cgt.global
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$5,296 |
| FY2025 | $0 |
| FY2024 | $47,470 |
| FY2023 | $107,864 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Grifols Bio Supplies Inc. | Los Angeles, CA | 621991 Blood and Organ Banks |
| Cell Culture Collective, Inc. | Encinitas, CA | 339113 Surgical Appliance and Supplies Manufacturing |
| Discovery Life Sciences, LLC | Huntsville, AL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Advanced Biomedical Laboratories L.l.c | Cinnaminson, NJ | 621511 Medical Laboratories |
| Quest Diagnostics Incorporated | Baltimore, MD | 621511 Medical Laboratories |
About the company
Stemexpress, LLC, doing business as CGT Global, is a small disadvantaged woman-owned business located in Folsom, California, specializing in providing human biological samples and specimen collection services for research and development in the life sciences. Registered in SAM.gov since July 30, 2012, the company has established itself as a key supplier of human donor biological materials to federal research agencies, with a focus on supporting advanced medical and scientific research initiatives.
The company has secured multiple federal contract awards primarily from health-related agencies, including the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and specific institutes like the National Cancer Institute and National Human Genome Research Institute. Their contract awards, ranging from $12,010 to $396,400, have involved supplying specialized biological samples such as human donor blood, COVID-19 positive serum samples, breast tumor specimens, and mobilized leukopak cells for various research purposes. These contracts typically involve providing biological materials for bioassay development, product development, genomic research, and scientific testing. Most of their awards have been purchase orders without specific set-aside designations, though one FDA contract was designated as a total small business set-aside. The contracts demonstrate Stemexpress's capability to support critical research efforts, including pandemic-related studies and advanced medical research requiring specialized human biological samples.
SBA capabilities narrative
Established in 2010, California-based StemExpress, LLC is a leading biospecimen provider supporting research, clinical trials, and drug development. Women-owned and operated with over 10 years of industry experience, StemExpress develops custom products and procedures to Academic, Biotechnological, Diagnostic, Pharmaceutical, and Contract Research Organizations (CRO's), ensuring all unique needs are met. To view more on our Federal Contracting please visit Fedlinks.
Quick answers
Is Stemexpress, LLC registered in SAM.gov?
Yes. Stemexpress, LLC's SAM.gov registration is active through June 10, 2027.
How much has Stemexpress, LLC received in federal contracts?
Federal contracts obligated $150,038 to Stemexpress, LLC in fiscal years 2023 through 2027.
What is Stemexpress, LLC's most recent federal award?
Stemexpress, LLC's most recent federal contract award is Human donor blood for bioassay development (75F40124P00405), from Food and Drug Administration, on September 6, 2024.
On GovTribe
See Stemexpress, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors